Vaccination With Tetanus and KLH to Assess Immune Responses.

NCT00000105 · clinicaltrials.gov ↗

TERMINATED

Status

112

Enrollment

OTHER

Sponsor class

Stopped Replaced by another study.

Conditions

Cancer

Interventions

BIOLOGICAL: Intracel KLH Vaccine
BIOLOGICAL: Biosyn KLH
DRUG: Montanide ISA51
BIOLOGICAL: Tetanus toxoid

Sponsor

Masonic Cancer Center, University of Minnesota